CAMBRIDGE, Mass., Oct. 4, 2018 /PRNewswire-iReach/ -- rHEALTH LLC, an innovative digital health solutions company, announced today that it has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application No. 14/645,388, entitled “Sample Consumable and Loader” filed by its affiliate company, DNA Medicine Institute (DMI). This...Read more
Recent Posts by DMI
Dr. Chan will be presenting a talk titled, "XPRIZE Tricorders and Point-of-Consumer Blood Diagnostics: Where are we now?" at the Athena Society, Corfu, Greece on September 8, 2018. http://athenasociety.org...Read more
CAMBRIDGE, Mass., Aug. 20, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is a subject of NASA’s Civilian Commercial Readiness Pilot Program (CCRPP). Recipients of CCRPP awards must not only demonstrate maturation of technology that aligns with NASA interests, but also...Read more
CAMBRIDGE, Mass., March 27, 2018 - rHEALTH LLC announces the issuance of a new patent in the United States for instrument industrial design filed by DNA Medicine Institute, DMI. The design contributes to the diverse measurement capabilities of the rHEALTH digital health platform, which represents broad innovations in testing technologies. The U.S. Patent and Trademark Office...Read more
CAMBRIDGE, Mass., Feb. 6, 2018 -- DNA Medicine Institute, Inc., and its affiliate rHEALTH LLC, a digital health solutions company, today announced that the rHEALTH technology is the subject of a partnership with the National Aeronautics and Space Administration (NASA) and the United States Air Force (USAF). This is done via Phase IIE and III...Read more
Recent Comments by DMI
No comments by DMI yet.